Clinical Drug Investigation

Acknowledgement
pp. 677-679(3)
Author: Adis International Limited,

Functional Half-Life is a Meaningful Descriptor of Steady-State Pharmacokinetics of an Extended-Release Formulation of a Rapidly Cleared Drug: As Shown by Once-Daily Divalproex-ER
pp. 681-690(10)
Authors: Dutta, Sandeep; Reed, Ronald C.

Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive Breast Cancer: A Phase II Study
pp. 691-701(11)
Authors: Sarid, David; Ron, Ilan G.; Sperber, Fani; Stadler, Yona; Kahan, Perry; Kovner, Felix; Ben-Yosef, Rami; Marmor, Sylvia; Grinberg, Yulia; Maimon, Natalie; Weinstein, Juliana; Yaal-Hahoshen, Neora

Comparison of Diurnal Intraocular Pressure Control by Latanoprost versus Travoprost: Results of an Observational Survey
pp. 703-714(12)
Authors: Denis, Philippe; Launois, Robert; Devaux, Marion; Berdeaux, Gilles

Evaluation of Chromogranin A Expression in Patients with Non-Neuroendocrine Tumours
pp. 715-722(8)
Authors: Tropea, F.; Baldari, S.; Restifo, G.; Fiorillo, M.T.; Surace, P.; Herberg, A.

Role of Androgen Ablation with Low-Dose-Rate Brachytherapy in the Treatment of Prostate Cancer
pp. 723-731(9)
Authors: Jani, Ashesh B.; Shoushtari, Asal; Feinstein, Jeffrey M.

Real-Life Treatment of Acute Exacerbations of Chronic Bronchitis with Moxifloxacin or Macrolides: A Comparative Post-Marketing Surveillance Study in General Practice
pp. 733-744(12)
Authors: Schaberg, T.; Möller, M.; File, T.; Stauch, K.; Landen, H.

Metoclopramide-Induced Delayed Non-Thrombocytopenic Purpuric Rash
pp. 745-747(3)
Authors: Upputuri, S.; Prasad, S.